UC researchers reengineer segmentation of the spine
A multidisciplinary team of UC students led a major discovery in embryology
How cells shape complex tissues and organs during embryo development, which makes us what we are, has many mysteries.
New research from the University of Cincinnati has examined one such process which leads to the formation of vertebral column or spinal column. If this process is disrupted, it results in a birth defect called congenital scoliosis, or curvature of the spine. The UC research not only advanced understanding of how complex biological tissues form, but it could also lead to possible treatments for scoliosis in the future.
The research was published in the journal Nature.
“We are studying a basic science problem, the formation of the spinal column, the vertebral backbone that we all have,” says Ertuğrul Özbudak, PhD, professor in the Department of Pediatrics at the UC College of Medicine’s Division of Developmental Biology as well as Cincinnati Children’s Hospital Medical Center and lead author on the study. “By discovering the core mechanism governing it, we are able to reengineer this mechanism in mutant zebrafish which normally lack that process.”
Özbudak says in all vertebrate species, including humans, the spinal column is composed of segmented vertebral discs. Those discs that form the spine originate in embryonic blueprint segments called somites. As the embryo body elongates in all vertebrate species, it is cut into somites by a “biological clock knife.”
“As humans, we all pass through that knife-cutting process thanks to clock genes that express like blades,” says Özbudak. “There is a biological clock controlling this. Each time that clock ticks, the knife comes down and then separates the disc precursors, somites, from the others that will form later on.
“Some genes are part of this clock. When they are mutated, it results in scoliosis because there is no longer a knife that is cutting,” he adds. “By discovering this unknown hierarchy and imitating it with pharmaceutical drugs, we are able to now restore and reengineer that missing segmentation in the mutants which miss the molecular clock.”
Özbudak says the four UC students worked on the project and all contributed in different ways, bringing different skills and talents to the research. Chandel Angad Singh, a second-year doctoral student in the systems physiology graduate program, engineered a genetically modified animal model while Didar Saparov, a third-year doctoral student in the molecular and developmental biology graduate program at Cincinnati Children's Hospital, conducted experiments with pharmaceutical drugs. Oriana Zinani, now a doctoral graduate from the molecular and developmental biologyB program, verified the precision of a genetic reporter fish for the molecular clock. Nick Clason, as an undergraduate co-op intern from the computer science department, contributed to the molecular simulations involved in the study.
“They had different backgrounds as undergraduates and they all did research in my lab,” Özbudak says of the students. “They formed a nice multidisciplinary team. In their bachelor’s degree [studies] Didar, Angad and Oriana majored in physics, biomedical engineering and biology, respectively. The team is led by Dr. Muhammed Simsek, a senior postdoctoral fellow in my lab at Cincinnati Children’s Hospital.”
Özbudak says the publication of the research has triggered positive responses from other scientists internationally.
“They are finding this study important and paradigm-shifting. We are hoping it will energize not only our lab members working on this project, but also several labs across the globe,” he says. “In a globalized society, hopefully everyone else will pitch in as well, and researchers from different countries and different universities will take these results and push them forward.
“Collectively, we will have a better understanding of why certain mutations cause diseases and we’ll understand the mechanisms behind it which will one day be helpful in curing congenital scoliosis.”
Lead image/Chuttersnap
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
GIVEHOPE and BSI Engineering Celebrate Ten Years of Driving Research
August 3, 2021
Years after two personal losses from pancreatic cancer, Cincinnati-based nonprofit GIVEHOPE and consulting firm BSI Engineering are celebrating a philanthropic partnership that has funded 13 pilot research projects at the University of Cincinnati Cancer Center.
Finding community and building a future
July 9, 2021
As a University of Cincinnati College of Medicine student, Sarah Appeadu, MD, ’21, remembers journaling on the “3 Cs” that got her through medical school: Community, community, community. Now, when she lists the people who supported her through four years of training—the last year in a global pandemic—it keeps growing: her family, her church, her classmates, and the college’s Office of Student Affairs and Office of Diversity, Equity and Inclusion. “I look back and it was such a crucial time to really be nurtured in that way,” she says. “I’m so thankful that I had those people. It shows being around the right people really mattered. That’s my same hope for residency even.”
New York Times: Flint Weighs Scope of Harm to Children Caused by Lead in Water
February 1, 2016
Kim Dietrich, a professor of environmental health at UC's College of Medicine, is quoted in this story on the medical problems that could develop among the thousands of young children exposed to lead-contaminated water in Flint, Mich.
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
February 18, 2016
Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients.
UC Receives $1.9 Million to Study Pain
February 15, 2016
Jun-Ming Zhang, MD, of the UC College of Medicine, is the principal investigator of a $1.95 million grant to study the interacting roles of the sympathetic and sensory nervous and immune systems in back and neuropathic pain models.
MD Magazine: Generic Drug Equally Effective in Epilespy
February 22, 2016
Michael Privitera, MD, a professor of neurology at UC's College of Medicine and director of the Epilepsy Center at the UC Neuroscience Institute, is featured in this story about research he led that examined the efficacy of generic drug substitution for epilepsy.
UC to Host Regional Conference for Latino Medical Student Association
February 10, 2016
The University of Cincinnati chapter of the Latino Medical Student Association (LMSA) will host a Midwest regional conference Feb. 26-28, 2016, at the College of Medicine.
Heart Disease Still Top Killer of American Women and Men, Symptoms Differ
February 1, 2016
Women tend to get palpitations, shortness of breath and "sharp" chest pain when suffering heart attacks, explains Stephanie Dunlap, DO, in the UC College of Medicine.
Philosophy Professor Explores Fine Lines Between Right and Wrong in March 29 Public Lecture
March 13, 2016
What distinguishes psychopaths from the rest of us? UC Professor Heidi Maibom offers some clues at a 3:30 p.m. lecture, March 29, in the Russell C. Myers Alumni Center.
Patient Attributes Phase 1 Clinical Trial, Research to Keeping Him Alive
February 29, 2016
Roy Hartman, 74, a Milford, Ohio, resident says what he thought was pneumonia sent him to urgent care on Christmas Eve 2012.